Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01055977
Other study ID # NIS-CCZ-CRE-2009/1
Secondary ID
Status Completed
Phase N/A
First received January 25, 2010
Last updated August 29, 2011
Start date February 2010
Est. completion date June 2010

Study information

Verified date August 2011
Source AstraZeneca
Contact n/a
Is FDA regulated No
Health authority Czech Republic: State Institute for Drug Control
Study type Observational

Clinical Trial Summary

Statins are the first choice treatment of dyslipidemia, a major contributor to cardiovascular diseases. Statins also have enough evidence to demonstrate decrease of morbidity and mortality from cardiovascular diseases. Even though statin therapy is effective treatment of dyslipidaemia not all patients reach the goal levels.

The aim of the study is to estimate proportion of patients who achieved the therapeutic goal (LDL-C. total cholesterol, HDL-C and triglycerides levels) after at least one year of a statin therapy.


Recruitment information / eligibility

Status Completed
Enrollment 3253
Est. completion date June 2010
Est. primary completion date June 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Documented statin therapy for at least 12 months

- Available two LDL-C values: one at the beginning of statin therapy or at the time when patient comes to a specialist; and the other one at least after 12 months of treatment. The latter value should not be older than 6 months.

Exclusion Criteria:

Study Design

Time Perspective: Retrospective


Related Conditions & MeSH terms


Locations

Country Name City State
Czech Republic Research Site Benesov
Czech Republic Research Site Beroun
Czech Republic Research Site Blansko
Czech Republic Research Site Bohumin
Czech Republic Research Site Boskovice
Czech Republic Research Site Brandys nad Labem
Czech Republic Research Site Brno
Czech Republic Research Site Ceska Lipa
Czech Republic Research Site ceske Budejovice
Czech Republic Research Site cesky Krumlov
Czech Republic Research Site Cheb
Czech Republic Research Site Chomutov
Czech Republic Research Site Chrudim
Czech Republic Research Site Decin
Czech Republic Research Site Domazlice
Czech Republic Research Site Dvur Kralove nad Labem
Czech Republic Research Site Frydek-Mistek
Czech Republic Research Site Havirov
Czech Republic Research Site Havlickuv Brod
Czech Republic Research Site Hradec Kralove
Czech Republic Research Site Hustopece
Czech Republic Research Site Ivancice
Czech Republic Research Site Jablonec nad Nisou
Czech Republic Research Site Jesenik
Czech Republic Research Site Jicin
Czech Republic Research Site Jihlava
Czech Republic Research Site Jindrichuv Hradec
Czech Republic Research Site Karlovy Vary
Czech Republic Research Site Karvina
Czech Republic Research Site Kladno
Czech Republic Research Site Kolin
Czech Republic Research Site Krnov
Czech Republic Research Site Kurim
Czech Republic Research Site Kutna Hora
Czech Republic Research Site Kyjov
Czech Republic Research Site Liberec
Czech Republic Research Site Litomerice
Czech Republic Research Site Louny
Czech Republic Research Site Melnik
Czech Republic Research Site Mestec Kralove
Czech Republic Research Site Mikulov
Czech Republic Research Site Milevsko
Czech Republic Research Site Mlada Boleslav
Czech Republic Research Site Moravska Trebova
Czech Republic Research Site Moravske Budejovice
Czech Republic Research Site Moravsky Krumlov
Czech Republic Research Site Most
Czech Republic Research Site Nachod
Czech Republic Research Site Novy Bydzov
Czech Republic Research Site Olomouc
Czech Republic Research Site Opava
Czech Republic Research Site Orlova
Czech Republic Research Site Ostrava
Czech Republic Research Site Ostrov nad Ohri
Czech Republic Research Site Pardubice
Czech Republic Research Site Pelhrimov
Czech Republic Research Site Pisek
Czech Republic Research Site Plzen
Czech Republic Research Site Police nad Metuji
Czech Republic Research Site Policka
Czech Republic Research Site Prachatice
Czech Republic Research Site Praha 1
Czech Republic Research Site Praha 10
Czech Republic Research Site Praha 2
Czech Republic Research Site Praha 3
Czech Republic Research Site Praha 4
Czech Republic Research Site Praha 5
Czech Republic Research Site Praha 6
Czech Republic Research Site Praha 8
Czech Republic Research Site Praha 9
Czech Republic Research Site Prerov
Czech Republic Research Site Prestice
Czech Republic Research Site Pribram
Czech Republic Research Site Prostejov
Czech Republic Research Site Rakovnik
Czech Republic Research Site Roudnice nad Labem
Czech Republic Research Site Roznov pod Radhostem
Czech Republic Research Site Rychnov nad Kneznou
Czech Republic Research Site Semily
Czech Republic Research Site Slany
Czech Republic Research Site Smirice
Czech Republic Research Site Sternberk
Czech Republic Research Site Strakonice
Czech Republic Research Site Susice
Czech Republic Research Site Svitavy
Czech Republic Research Site Tabor
Czech Republic Research Site Teplice
Czech Republic Research Site Tisnov
Czech Republic Research Site Trebic
Czech Republic Research Site Trinec
Czech Republic Research Site Trutnov
Czech Republic Research Site Turnov
Czech Republic Research Site Uherske Hradiste
Czech Republic Research Site Usti nad Labem
Czech Republic Research Site Valasske Klobouky
Czech Republic Research Site Veseli nad Moravou
Czech Republic Research Site Vitkovice
Czech Republic Research Site Vsetin
Czech Republic Research Site Vyskov
Czech Republic Research Site Vysoke Myto
Czech Republic Research Site Zamberk
Czech Republic Research Site Zlin
Czech Republic Research Site Znojmo

Sponsors (1)

Lead Sponsor Collaborator
AstraZeneca

Country where clinical trial is conducted

Czech Republic, 

Outcome

Type Measure Description Time frame Safety issue
Primary LDL-C one year No
Secondary Total cholesterol one year No
Secondary HDL-C one year No
Secondary triglycerides one year No
See also
  Status Clinical Trial Phase
Completed NCT02230241 - CEntralized Pan-Russian Survey of tHE Undertreatment of hypercholeSterolemia II (CEPHEUS II) N/A
Completed NCT04641299 - A Study of AZD8233 in Participants With Dyslipidemia Phase 2
Completed NCT01451918 - Regulation of Intestinal and Hepatic Lipoprotein Secretion by Resveratrol Phase 2
Recruiting NCT01212328 - A Multi-site, Individually Randomized, Controlled Translation Trial of Integrated and Comprehensive Care Strategies to Reduce Cardiovascular Disease (CVD) Risk Among 1,120 Type 2 Diabetes Mellitus(T2DM) Patients in South Asia N/A
Completed NCT01221584 - Centralized Pan-Russian Survey on the Undertreatment of Hypercholesterolemia N/A
Completed NCT00654225 - Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS) Phase 3
Withdrawn NCT02557412 - Effect of Nasal CPAP on Lipid Profile in Patients With Dyslipidaemia and Sleep Apnea N/A
Completed NCT00653965 - Treatment of Hypercholesterolaemia in Hispanic Subjects (STARSHIP) Phase 3
Recruiting NCT04442334 - The European NAFLD Registry
Completed NCT00653744 - Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES) Phase 3
Completed NCT01632358 - Safety and Pharmacokinetis of TAP311 in Dyslipidemic Patients Phase 1
Completed NCT02523391 - Bioequivalence Study of Capsule and Tablet Formulations of TA-8995 Phase 1
Completed NCT00474864 - Study To Evaluate The Effects Of GW856553 On Endothelial Function/Vascular Compliance In Subjects With Dyslipidaemia. Phase 2
Completed NCT00659321 - Efficacy of Nicotine Acid on Dyslipidaemia in Patients With Metabolic Syndrome Phase 3
Completed NCT00654602 - 48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety Phase 3
Recruiting NCT05979428 - A Study to Look at How Safe a New Medicine (NNC0491-6075) is in Healthy People and in Participants With High Levels of Fat in the Blood Phase 1
Completed NCT02241759 - Study of the Electrocardiographic Effects of TA-8995 Phase 1
Completed NCT00158899 - GW501516 In Subjects Who Have Low Level Of High-Density Lipoprotein Cholesterol Phase 2